By contrast, elevated expression of PPARD was correlated with worse clinical outcomes of patients with LGG (p = 0.040), LIHC (p = 0.018), and SARC (p = 0.011) while elevated PPARD led to better clinical outcomes in BLCA (p = 0.025) and UVM (p = 0.006). Here, PPARD is linked to bladder transitional cell carcinoma.